EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The sphingosine‐1‐phosphate receptor 1 modulator ponesimod repairs cuprizone‐induced demyelination and induces oligodendrocyte differentiation

Emily Willems iD, Melissa Schepers iD, Elisabeth Piccart, Esther Wolfs iD, Niels Hellings iD, Maria Ait-Tihyaty, Tim Vanmierlo iD

The FASEB Journal · 31.01.2024 · 38 (2)

DOI: 10.1096/fj.202301557rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 20.01.2024. Verfasst von Emily Willems und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium. Hauptthemen laut MEDLINE: Cuprizone, Demyelinating Diseases, Thiazoles. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Janssen Research and Development (JRD).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sphingosine‐1‐phosphate receptor (S1PR) modulators are clinically used to treat relapse‐remitting multiple sclerosis (MS) and the early phase of progressive MS when inflammation still prevails. In the periphery, S1PR modulators prevent lymphocyte egress from lymph nodes, hence hampering neuroinflammation. Recent findings suggest a role for S1PR modulation in remyelination. As the Giα‐coupled S1P1 subtype is the most prominently expressed S1PR in oligodendrocyte precursor cells (OPCs), selective modulation (functional antagonism) of S1P1 may have direct effects on OPC functionality. We hypothesized that functional antagonism of S1P1 by ponesimod induces remyelination by boosting OPC differentiation. In the cuprizone mouse model of demyelination, we found ponesimod to decrease the latency time of visual evoked potentials compared to vehicle conditions, which is indicative of functional remyelination. In addition, the Y maze spontaneous alternations test revealed that ponesimod reversed cuprizone‐induced working memory deficits. Myelin basic protein (MBP) immunohistochemistry and transmission electron microscopy of the corpus callosum revealed an increase in myelination upon ponesimod treatment. Moreover, treatment with ponesimod alone or in combination with A971432, an S1P5 monoselective modulator, significantly increased primary mouse OPC differentiation based on O4 immunocytochemistry. In conclusion, S1P1 functional antagonism by ponesimod increases remyelination in the cuprizone model of demyelination and significantly increases OPC differentiation in vitro.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CuprizoneDemyelinating DiseasesThiazolesMiceAnimalsSphingosine-1-Phosphate ReceptorsOligodendrogliaEvoked Potentials, VisualCell DifferentiationMice, Inbred C57BLMyelin SheathDisease Models, Animal

Stichwörter der Autor:innen

cuprizonemultiple sclerosisoligodendrocyte precursorremyelinationvisual evoked potentials

Substanzen

CuprizoneSphingosine-1-Phosphate ReceptorsponesimodThiazoles

Autor:innen und Institutionen

  • Department of Neuroscience, Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.
  • Department Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands.
  • University MS Center (UMSC) Hasselt-Pelt, Hasselt, Belgium.
  • Department of Cardio and Organ Systems, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
  • Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
  • Janssen Research & Development, LLC, Titusville, New Jersey, USA.

ORCID-Profile: Emily Willems, Melissa Schepers, Esther Wolfs, Niels Hellings, Tim Vanmierlo

Förderung

  • Janssen Research and Development (JRD)

Zitieren

APA

Willems, E., Schepers, M., Piccart, E., Wolfs, E., Hellings, N., Ait-Tihyaty, M., & Vanmierlo, T. (2024). The sphingosine‐1‐phosphate receptor 1 modulator ponesimod repairs cuprizone‐induced demyelination and induces oligodendrocyte differentiation. The FASEB Journal, 38(2). https://doi.org/10.1096/fj.202301557rr

Vancouver

Willems E, Schepers M, Piccart E, Wolfs E, Hellings N, Ait-Tihyaty M, et al. The sphingosine‐1‐phosphate receptor 1 modulator ponesimod repairs cuprizone‐induced demyelination and induces oligodendrocyte differentiation. The FASEB Journal. 2024;38(2). doi:10.1096/fj.202301557rr

BibTeX
@article{Willems2024,
  author = {Willems, Emily and Schepers, Melissa and Piccart, Elisabeth and Wolfs, Esther and Hellings, Niels and Ait-Tihyaty, Maria and Vanmierlo, Tim},
  title = {The sphingosine‐1‐phosphate receptor 1 modulator ponesimod repairs cuprizone‐induced demyelination and induces oligodendrocyte differentiation},
  journal = {The FASEB Journal},
  year = {2024},
  volume = {38},
  number = {2},
  doi = {10.1096/fj.202301557rr}
}
Kostenlos starten →